Dr. Steven Nissen draws lessons for healthcare providers from Cleveland Clinic’s latest national survey of adults’ heart health knowledge and practices.
The new ACC/AHA recommendations are a helpful development, but Cleveland Clinic experts say they miss the boat on patients with diabetes and the need to individualize treatment.
The recent landmark trial conclusively proved the inflammatory hypothesis of atherothrombosis. But it did a good deal more. Dr. Steven Nissen explains.
More than 30 expert faculty gather in Cleveland Nov. 3 to explore the state of the art in CABG and PCI via “How I Do It Videos,” pro/con debates and more.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
This five-minute explainer on the CANTOS, REVEAL and COMPASS studies puts the findings in real-world context for cardiologists.
This substudy of the huge PRECISION trial shows that clinicians need to weigh the potential dangers of worsened blood pressure control when considering chronic use of NSAIDs — especially ibuprofen.
This infographic, derived from an editorial by Dr. Steven Nissen, outlines the causes, effects and high stakes of widespread misinformation about statins and cholesterol.
As yet another study shows that nonadherence to statin therapy can carry grave consequences, Dr. Steven Nissen argues it’s time for physicians to actively counter online misinformation about the drugs.
As the dust settles in the wake of the FOURIER trial results, how should we translate them into practice? Dr. Steven Nissen shares his thoughts on this, as well as PCSK9 inhibitor safety, in this two-minute video.
The advent of diabetes drugs that curb cardiovascular morbidity and mortality was hailed as the year’s No. 2 advance at Cleveland Clinic’s 2016 Medical Innovation Summit. In this Q&A, Dr. Steven Nissen reflects on the development’s rich backstory.